Mouse Models of Human Cancer

Mouse Models of Human Cancer

Online ISBN: 9780471675068

DOI: 10.1002/0471675067

Editors & Contributors


Editor

Eric C. Holland
Departments of Surgery, Neurology, and Cell Biology, Memorial Sloan Kettering Cancer Center
New York, New York

Contributors

Melvin E. Andersen, Ph.D.
Department of Biomathematics and Physical Sciences, CIIT Centers for Health Research, Research Triangle Park
North Carolina

Dalit Barkan, Ph.D.
National Cancer Institute, National Institutes of Health
Bethesda, Maryland

Stephen W. Barthold, D.V.M., Ph.D.
Center for Comparative Medicine, School of Medicine and Veterinary Medicine, University of California, Davis
Davis, California

Robert Benezra, Ph.D.
Department of Cell Biology, Memorial Sloan-Kettering Cancer Center
New York, New York

Dawnalyn Boggess, B.S.
The Jackson Laboratory
Bar Harbor, Maine

Marcus Bosenberg, M.D., Ph.D.
Department of Pathology, University of Vermont
Burlington, Vermont

Robert D. Cardiff, M.D., Ph.D.
Mutant Mouse Pathology Laboratory, Center for Comparative Medicine, University of California, Davis
Davis, California

Dawn S. Chandler, Ph.D.
Department of Molecular Genetics, The University of Texas M.D. Anderson Cancer Center
Houston, Texas

Thomas L. Chenevert, Ph.D.
Center for Molecular Imaging, University of Michigan, School of Medicine
Ann Arbor, Michigan

Christopher H. Contag, Ph.D.
Departments of Pediatrics, Radiology, and Microbiology and Immunology, Stanford School of Medicine
Stanford, California

Franco J. DeMayo, Ph.D.
Department of Molecular and Cellular Biology, Baylor College of Medicine
Houston, Texas

James E. Dennison, M.S.
Quantitative and Computational Toxicology Group, Center for Environmental Toxicology and Technology, Department of Environmental and Radiological Health Sciences, Colorado State University
Fort Collins, Colorado

Katharine Ellwood-Yen, Ph.D.
Department of Hematology and Oncology, University of California, Los Angeles
Los Angeles, California

Michael FW Festing, Ph.D., D.Sc.
Medical Research Council Toxicology Unit, University of Leicester
Leicester, United Kingdom

Jeffrey E. Green, M.D.
National Cancer Institute, National Institutes of Health
Bethesda, Maryland

Silvia Grisendi, Ph.D.
Molecular Biology Program and Department of Pathology, Memorial Sloan-Kettering Cancer Center
New York, New York

Guillermina Lozano, Ph.D.
Department of Molecular Genetics, The University of Texas M.D. Anderson Cancer Center
Houston, Texas

David H. Gutmann, M.D., Ph.D.
Department of Neurology, Washington University School of Medicine
St. Louis, Missouri

Stephen S. Hecht, Ph.D.
Department of Laboratory Medicine and Pathology, University of Minnesota Cancer Center
Minneapolis, Minnesota

Eric C. Holland, M.D., Ph.D.
Departments of Surgery, Neurology, and Cell Biology, Memorial Sloan Kettering Cancer Center
New York, New York

Alan N. Houghton, M.D.
Immunology Program, Memorial Sloan-Kettering Cancer Center
New York, New York

Kent W. Hunter, Ph.D.
Laboratory of Population Genetics, National Cancer Institute, National Institutes of Health
Bethesda, Maryland

Scott C. Kogan, M.D.
Comprehensive Cancer Center and Department of Laboratory Medicine, University of California, San Francisco
San Francisco, California

Jason A. Koutcher, M.D., Ph.D.,
Departments of Medical Physics, Radiology, and Medicine, Memorial Sloan-Kettering Cancer Center
New York, New York

Jonathan M. Kurie, M.D.
Department of Thoracic and Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center
Houston, Texas

Carlisle P. Landel, Ph.D.
The Jackson Laboratory
Bar Harbor, Maine

Andrew B. Lassman, M.D.
Department of Neurology, Memorial Sloan-Kettering Cancer Center
New York, New York

Kai H. Liao, M.S.
Quantitative and Computational Toxicology Group, Center for Environmental Toxicology and Technology, Department of Chemical Engineering, Colorado State University
Fort Collins, Colorado

David Lyden, M.D., Ph.D.
Department of Pediatrics and the Children’s Blood Foundation Laboratories, Cornell University Medical College
New York, New York

Kenneth F. Manly, Ph.D.
Department of Cellular and Molecular Biology, Roswell Park Cancer Institute
Buffalo, New York

Alex Matter, M.D.
Novartis Institute for Tropical Diseases, Novartis International
Basel, Switzerland

Patrick McConville, Ph.D.
Molecular Imaging Research Inc.
Ann Arbor, Michigan

Taha Merghoub, Ph.D.
Immunology Program, Memorial Sloan-Kettering Cancer Center
New York, New York

Parviz Minoo, Ph.D.
Department of Pediatrics, Women and Children’s Hospital, University of Southern California
Los Angeles, California

Larry Mobraaten, Ph.D.
The Jackson Laboratory
Bar Harbor, Maine

Bradford A. Moffat, Ph.D.
Center for Molecular Imaging, University of Michigan, School of Medicine
Ann Arbor, Michigan

Cristina Montagna, Ph.D.
National Cancer Institute, National Institutes of Health
Bethesda, Maryland

Jonathan Moody, Ph.D.
Molecular Imaging Research Inc.
Ann Arbor, Michigan

Manickam Muruganandham, Ph.D.
Departments of Medical Physics, Radiology, and Medicine, Memorial Sloan-Kettering Cancer Center
New York, New York

Alexander Nikitin, M.D., Ph.D.
Department of Biomedical Sciences, Cornell University
Ithaca, New York

Sandra Orsulic, Ph.D.
Molecular Pathology Unit, Massachusetts General Hospital Cancer Center
Charlestown, Massachusetts

Ying C. Ou, Ph.D.
Human Genome Sciences, Inc.
Rockville, Maryland

Pier Paolo Pandolfi, M.D., Ph.D.
Molecular Biology Program and Department of Pathology, Memorial Sloan-Kettering Cancer Center
New York, New York

Arie Perry, M.D.
Division of Neuropathology, Washington University School of Medicine
St. Louis, Missouri

Shahin Rafii, M.D.
Department of Hematology-Oncology and Genetics Medicine, Cornell University Medical College
New York, New York

Reshma Rangwala, B.S.
Division of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University
Beaverton, Oregon

Alnawaz Rehemtulla, Ph.D.
Center for Molecular Imaging, University of Michigan, School of Medicine
Ann Arbor, Michigan

Brad Reisfeld, Ph.D.
Quantitative and Computational Toxicology Group, Center for Environmental Toxicology and Technology, Department of Chemical Engineering, Colorado State University
Fort Collins, Colorado

Thomas Ried, M.D. National Cancer Institute, National Institutes of Health
Bethesda, Maryland

Brian D. Ross, Ph.D.
Center for Molecular Imaging, University of Michigan, School of Medicine
Ann Arbor, Michigan

Charles Sawyers, M.D.
Department of Hematology and Oncology, University of California, Los Angeles
Los Angeles, California

William R. Sellers, M.D.
Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
Boston, Massachusetts

Kevin Shannon, M.D.
Department of Pediatrics, University of California, San Francisco
San Francisco, California

Larry S. Sherman, Ph.D.
Division of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University
Beaverton, Oregon

Kathleen A. Silva, B.S.
The Jackson Laboratory
Bar Harbor, Maine

John P. Sundberg, D.V.M., Ph.D.
The Jackson Laboratory
Bar Harbor, Maine

Michael Teitell, M.D., Ph.D.
Department of Pathology, David Geffen School of Medicine at University of California, Los Angeles
Los Angeles, California

David W. Threadgill, Ph.D.
Department of Genetics and Lineberger Comprehensive Cancer Center, University of North Carolina
Chapel Hill, North Carolina

Lene Uhrbom, Ph.D.
Rudbeck Laboratory, Uppsala University
Uppsala, Sweden

Jamey P. Weichert, Ph.D.
Department of Radiology, University of Wisconsin Medical School
Madison, Wisconsin

Brian Weiss, M.D.
Department of Pediatrics, University of California, San Francisco
San Francisco, California

Raymond S. H. Yang, Ph.D.
Quantitative and Computational Toxicology Group, Center for Environmental Toxicology and Technology, Department of Environmental and Radiological Health Sciences, Colorado State University
Fort Collins, Colorado

Fei Zou, Ph.D.
Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina

SEARCH